Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic neuropathy in diabetes. [electronic resource]
- Diabetologia Feb 2004
- 331-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0012-186X
10.1007/s00125-003-1298-y doi
Animals Apoptosis Blood Glucose--drug effects Body Weight--drug effects Caspase 3 Caspase Inhibitors Caspases--metabolism Cell Line, Tumor Choline O-Acetyltransferase--metabolism Diabetes Mellitus, Experimental--complications Diabetic Neuropathies--etiology Drug Synergism Enzyme Inhibitors--pharmacology Esophagogastric Junction--chemistry Ganglia--chemistry Gene Expression--drug effects Glucose--pharmacology Glycation End Products, Advanced--blood Immunohistochemistry Insulin--pharmacology Male Nitrergic Neurons--drug effects Nitric Oxide--physiology Nitric Oxide Synthase--antagonists & inhibitors Nitric Oxide Synthase Type I Penis--chemistry Rats Rats, Wistar Reactive Oxygen Species--metabolism Receptor for Advanced Glycation End Products Receptors, Immunologic--metabolism Serum Albumin--chemistry Tretinoin--pharmacology